Chao-Yi Wu is a faculty member at Harvard Medical School and Massachusetts General Hospital, specializing in cognitive aging, healthcare, and data science. Her research focuses on digital biomarkers for Alzheimer's disease and leveraging sensor technology to promote healthy aging. She previously worked at Oregon Health & Science University and the University of Pittsburgh, contributing to high-impact studies on cognitive decline and rehabilitation. With a PhD in Rehabilitation Science from the University of Pittsburgh and an MS in Data Science from UT Austin, she combines healthcare expertise with advanced data analytics. Her recent work explores nicotinamide riboside supplementation’s effects on Alzheimer's biomarkers.